Deborah Morosini, EVP, Chief of Clinical Affairs at Prelude Therapeutics Inc (PRLD), sold 6,446 shares at $40.29 ($260K) on 2021-04-29, disclosed to the SEC on 2021-04-30.
Open-market sale of $260k PRLD by EVP, Chief of Clinical Affairs. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $40.29 | 3,223 | $130K | 50.0% |
| 2 | $40.29 | 3,223 | $130K | 50.0% |
| Total | $40.29 avg | 6,446 | $260K | 100% |
| Filing → |
| PRLD | SELL | 2021-04-15 | $4K | — | Filing → |
| PRLD | SELL | 2021-04-09 | $40K | — | Filing → |
| PRLD | BUY | 2020-09-29 | $8K | — | Filing → |